1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69281AA62FD028EA4852576B80021B7D1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/supporting-successful-diabetes-product-launches-tactics-for-educating-payers?opendocument
18
19opendocument
2054.161.31.247
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Product Launch Market Entry: Metabolic and Cardiovascular Diseases

Supporting Successful Diabetes Product Launches: Tactics for Educating Payers

ID: 5073


Features:

24 Info Graphics

7 Data Graphics

80+ Metrics

8 Narratives


Pages/Slides: 42


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Diabetes Product Launches: Tactics for Educating Payers"

Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents.

Study Overview

Effective payer education of new products - in particular new diabetes therapies - has become paramount in the face of the ever-growing role of the payer and government sectors in the marketplace. Specifically, the cost of diabetes therapies necessitates that payers are not only well educated in the benefits of the therapies but also how the products are different from existing treatments. This Best Practices, LLC study delivers benchmarks around timing of education tactics for payers and identifies the most important edcation activities for payers. Additionally, this study contains qualitative insights from industry executives regarding methods for effectively communicating with payers. Executives can use this research to compare their strategies and tactics with those of leading organizations.

Key Topics

  • Summary of Key Insights, Findings and Lessons Learned
  • Research Participants, Launch Experience, and Therapeutic Area Demographics
  • Post-Approval Early Access Programs: Getting to First Reimbursed Prescription Quickly
  • Payer Education Starts Early: Focus on Cost and Outcomes
  • Voices From the Field: Best Practices, Lessons Learned & Pitfalls
  • Future Trends & Issues

Sample Key Metrics
  • Timing of Education Activities for Payers and Government Entities
  • Top Five Education Activities for Payers and Government Entities
  • Mix of Market Education Investment

Sample Key Findings

Winning Payers On Board: Commence work earlier than in past to win payers, who are increasingly important to market entry in diabetes. Focus on cost and health outcomes. Understand payer needs and engineer them increasingly into clinical trials.

Methodology

Research was conducted through surveys and interviews. Research participants included 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies. Diabetes/Cardiovascular research participants included 11 executives and managers at 11 different industry leading companies. Interviewed nine selected participants.


Industries Profiled:
Pharmaceutical; Biotech; Health Care; Service; Medical Device; Technology; Manufacturing; Consumer Products; Diagnostic; Chemical


Companies Profiled:
GlaxoSmithKline; ARIAD; Pfizer; Integrated Communications Corp.; Novartis; Genitope Corporation; NeoVista; Inc.; Amgen; Novo Nordisk; Johnson & Johnson; AstraZeneca; Roche; Lilly; Bayer; Human Genome Sciences; Boehringer Ingelheim; Nobel Biocare; Abbott; Solvay Pharmaceuticals; Genentech; Sanofi-aventis; Smith & Nephew; Amylin; Janssen Cilag Pharmaceutical; Dr Reddy's Laboratories; Spectrum Pharmaceutical


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.